Baijin Life Science Holdings Limited (MNNGF)

OTCMKTS · Delayed Price · Currency is USD

0.1000

0.00 (0.00%)

Mar 7, 2025, 3:00 PM EST

Market Cap	148.61M +209.1%
Revenue (ttm)	11.39M -34.1%
Net Income	-4.83M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1000
Previous Close	0.1000
Day's Range	0.1000 - 0.1000
52-Week Range	0.0450 - 0.1000
Beta	-0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2026

About MNNGF

Baijin Life Science Holdings Limited, together with its subsidiaries, engages in the procurement, processing, design, production, and wholesale distribution of pearls and fine jewelry products in Hong Kong, the People’s Republic of China, the United States, and internationally. It operates through three segments: Jewellery Business, Skincare Business, and Strategic Investment. The company is involved in the research and development of cellular and large molecule drugs; clinical research services; research, development, and sale of medical devic... [Read more]

Industry Luxury Goods

Sector Consumer Discretionary

Founded 2014

Employees 84

Stock Exchange OTCMKTS

Ticker Symbol MNNGF

Financial Performance

In fiscal year 2026, MNNGF's revenue was 89.30 million, a decrease of -34.12% compared to the previous year's 135.56 million. Losses were -37.87 million, 11883.2% more than in 2025.

Financial numbers in HKD Financial Statements